Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors

Craig W. Lindsley, Kyle Allen Emmitte, Corey R. Hopkins, Thomas M. Bridges, Karen J. Gregory, Colleen M. Niswender, P. Jeffrey Conn

Research output: Contribution to journalReview article

73 Citations (Scopus)

Abstract

Allosteric modulation of GPCRs has initiated a new era of basic and translational discovery, filled with therapeutic promise yet fraught with caveats. Allosteric ligands stabilize unique conformations of the GPCR that afford fundamentally new receptors, capable of novel pharmacology, unprecedented subtype selectivity, and unique signal bias. This review provides a comprehensive overview of the basics of GPCR allosteric pharmacology, medicinal chemistry, drug metabolism, and validated approaches to address each of the major challenges and caveats. Then, the review narrows focus to highlight recent advances in the discovery of allosteric ligands for metabotropic glutamate receptor subtypes 1-5 and 7 (mGlu1-5,7) highlighting key concepts ("molecular switches", signal bias, heterodimers) and practical solutions to enable the development of tool compounds and clinical candidates. The review closes with a section on late-breaking new advances with allosteric ligands for other GPCRs and emerging data for endogenous allosteric modulators.

Original languageEnglish
Pages (from-to)6707-6741
Number of pages35
JournalChemical Reviews
Volume116
Issue number11
DOIs
StatePublished - 8 Jun 2016

Fingerprint

Metabotropic Glutamate Receptors
Modulators
Ligands
Metabolism
Conformations
Switches
Modulation
Pharmaceutical Preparations

Cite this

Lindsley, Craig W. ; Emmitte, Kyle Allen ; Hopkins, Corey R. ; Bridges, Thomas M. ; Gregory, Karen J. ; Niswender, Colleen M. ; Conn, P. Jeffrey. / Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery : Recent Advances with Metabotropic Glutamate Receptors. In: Chemical Reviews. 2016 ; Vol. 116, No. 11. pp. 6707-6741.
@article{1c340f5564134efeb46a76e421ffe70a,
title = "Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors",
abstract = "Allosteric modulation of GPCRs has initiated a new era of basic and translational discovery, filled with therapeutic promise yet fraught with caveats. Allosteric ligands stabilize unique conformations of the GPCR that afford fundamentally new receptors, capable of novel pharmacology, unprecedented subtype selectivity, and unique signal bias. This review provides a comprehensive overview of the basics of GPCR allosteric pharmacology, medicinal chemistry, drug metabolism, and validated approaches to address each of the major challenges and caveats. Then, the review narrows focus to highlight recent advances in the discovery of allosteric ligands for metabotropic glutamate receptor subtypes 1-5 and 7 (mGlu1-5,7) highlighting key concepts ({"}molecular switches{"}, signal bias, heterodimers) and practical solutions to enable the development of tool compounds and clinical candidates. The review closes with a section on late-breaking new advances with allosteric ligands for other GPCRs and emerging data for endogenous allosteric modulators.",
author = "Lindsley, {Craig W.} and Emmitte, {Kyle Allen} and Hopkins, {Corey R.} and Bridges, {Thomas M.} and Gregory, {Karen J.} and Niswender, {Colleen M.} and Conn, {P. Jeffrey}",
year = "2016",
month = "6",
day = "8",
doi = "10.1021/acs.chemrev.5b00656",
language = "English",
volume = "116",
pages = "6707--6741",
journal = "Chemical Reviews",
issn = "0009-2665",
publisher = "American Chemical Society",
number = "11",

}

Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery : Recent Advances with Metabotropic Glutamate Receptors. / Lindsley, Craig W.; Emmitte, Kyle Allen; Hopkins, Corey R.; Bridges, Thomas M.; Gregory, Karen J.; Niswender, Colleen M.; Conn, P. Jeffrey.

In: Chemical Reviews, Vol. 116, No. 11, 08.06.2016, p. 6707-6741.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery

T2 - Recent Advances with Metabotropic Glutamate Receptors

AU - Lindsley, Craig W.

AU - Emmitte, Kyle Allen

AU - Hopkins, Corey R.

AU - Bridges, Thomas M.

AU - Gregory, Karen J.

AU - Niswender, Colleen M.

AU - Conn, P. Jeffrey

PY - 2016/6/8

Y1 - 2016/6/8

N2 - Allosteric modulation of GPCRs has initiated a new era of basic and translational discovery, filled with therapeutic promise yet fraught with caveats. Allosteric ligands stabilize unique conformations of the GPCR that afford fundamentally new receptors, capable of novel pharmacology, unprecedented subtype selectivity, and unique signal bias. This review provides a comprehensive overview of the basics of GPCR allosteric pharmacology, medicinal chemistry, drug metabolism, and validated approaches to address each of the major challenges and caveats. Then, the review narrows focus to highlight recent advances in the discovery of allosteric ligands for metabotropic glutamate receptor subtypes 1-5 and 7 (mGlu1-5,7) highlighting key concepts ("molecular switches", signal bias, heterodimers) and practical solutions to enable the development of tool compounds and clinical candidates. The review closes with a section on late-breaking new advances with allosteric ligands for other GPCRs and emerging data for endogenous allosteric modulators.

AB - Allosteric modulation of GPCRs has initiated a new era of basic and translational discovery, filled with therapeutic promise yet fraught with caveats. Allosteric ligands stabilize unique conformations of the GPCR that afford fundamentally new receptors, capable of novel pharmacology, unprecedented subtype selectivity, and unique signal bias. This review provides a comprehensive overview of the basics of GPCR allosteric pharmacology, medicinal chemistry, drug metabolism, and validated approaches to address each of the major challenges and caveats. Then, the review narrows focus to highlight recent advances in the discovery of allosteric ligands for metabotropic glutamate receptor subtypes 1-5 and 7 (mGlu1-5,7) highlighting key concepts ("molecular switches", signal bias, heterodimers) and practical solutions to enable the development of tool compounds and clinical candidates. The review closes with a section on late-breaking new advances with allosteric ligands for other GPCRs and emerging data for endogenous allosteric modulators.

UR - http://www.scopus.com/inward/record.url?scp=84974602761&partnerID=8YFLogxK

U2 - 10.1021/acs.chemrev.5b00656

DO - 10.1021/acs.chemrev.5b00656

M3 - Review article

C2 - 26882314

AN - SCOPUS:84974602761

VL - 116

SP - 6707

EP - 6741

JO - Chemical Reviews

JF - Chemical Reviews

SN - 0009-2665

IS - 11

ER -